140 related articles for article (PubMed ID: 8927027)
1. Decrease in protein tyrosine phosphatase activities in vanadate-treated obese Zucker (fa/fa) rat liver.
Pugazhenthi S; Tanha F; Dahl B; Khandelwal RL
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):125-9. PubMed ID: 8927027
[TBL] [Abstract][Full Text] [Related]
2. Vanadate induces normolipidemia and a reduction in the levels of hepatic lipogenic enzymes in obese Zucker rat.
Pugazhenthi S; Hussain A; Yu B; Brownsey RW; Angel JF; Khandelwal RL
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):211-5. PubMed ID: 8927041
[TBL] [Abstract][Full Text] [Related]
3. Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus.
Ahmad F; Goldstein BJ
Metabolism; 1995 Sep; 44(9):1175-84. PubMed ID: 7666792
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of diabetes on adipocyte and liver phosphotyrosine and phosphoserine phosphatase activities.
Begum N; Sussman KE; Draznin B
Diabetes; 1991 Dec; 40(12):1620-9. PubMed ID: 1661692
[TBL] [Abstract][Full Text] [Related]
5. Hepatic phosphotyrosine phosphatase activity and its alterations in diabetic rats.
Meyerovitch J; Backer JM; Kahn CR
J Clin Invest; 1989 Sep; 84(3):976-83. PubMed ID: 2547842
[TBL] [Abstract][Full Text] [Related]
6. Effects of adenosine receptor antagonism on protein tyrosine phosphatase in rat skeletal muscle.
Crist GH; Xu B; Berkich DA; LaNoue KF
Int J Biochem Cell Biol; 2001 Aug; 33(8):817-30. PubMed ID: 11404185
[TBL] [Abstract][Full Text] [Related]
7. In vivo effects of vanadate on hepatic glycogen metabolizing and lipogenic enzymes in insulin-dependent and insulin-resistant diabetic animals.
Khandelwal RL; Pugazhenthi S
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):87-94. PubMed ID: 8927052
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of a Src homology 2 domain containing protein tyrosine phosphatase by vanadate in the primary culture of hepatocytes.
Pugazhenthi S; Tanha F; Dahl B; Khandelwal RL
Arch Biochem Biophys; 1996 Nov; 335(2):273-82. PubMed ID: 8914924
[TBL] [Abstract][Full Text] [Related]
9. Decreased skeletal muscle phosphotyrosine phosphatase (PTPase) activity towards insulin receptors in insulin-resistant Zucker rats measured by delayed Europium fluorescence.
Worm D; Handberg A; Hoppe E; Vinten J; Beck-Nielsen H
Diabetologia; 1996 Feb; 39(2):142-8. PubMed ID: 8635665
[TBL] [Abstract][Full Text] [Related]
10. Regulation of an hepatic low-M(r) membrane-associated protein-tyrosine phosphatase.
Tappia PS; Atkinson PG; Sharma RP; Sale GJ
Biochem J; 1993 May; 292 ( Pt 1)(Pt 1):1-5. PubMed ID: 8503835
[TBL] [Abstract][Full Text] [Related]
11. Insulin differentially regulates protein phosphotyrosine phosphatase activity in rat hepatoma cells.
Meyerovitch J; Backer JM; Csermely P; Shoelson SE; Kahn CR
Biochemistry; 1992 Oct; 31(42):10338-44. PubMed ID: 1420153
[TBL] [Abstract][Full Text] [Related]
12. Oral vanadate decreases muscle insulin resistance in obese fa/fa rats.
Brichard SM; Ongemba LN; Henquin JC
Diabetologia; 1992 Jun; 35(6):522-7. PubMed ID: 1612224
[TBL] [Abstract][Full Text] [Related]
13. Phenylarsine oxide and vanadate: apparent paradox of inhibition of protein phosphotyrosine phosphatases in rat adipocytes.
Li J; Elberg G; Shechter Y
Biochim Biophys Acta; 1996 Jul; 1312(3):223-30. PubMed ID: 8703991
[TBL] [Abstract][Full Text] [Related]
14. Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus.
Meyerovitch J; Rothenberg P; Shechter Y; Bonner-Weir S; Kahn CR
J Clin Invest; 1991 Apr; 87(4):1286-94. PubMed ID: 1707061
[TBL] [Abstract][Full Text] [Related]
15. Membrane-associated N-myristoyltransferase activity is reduced in obese (fa/fa) Zucker rat liver.
King MJ; Pugazhenthi S; Khandelwal RL; Sharma RK
Biochem Biophys Res Commun; 1993 Oct; 196(2):665-70. PubMed ID: 8240341
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of multiple hepatic protein tyrosine phosphatases in alloxan diabetic rats.
Boylan JM; Brautigan DL; Madden J; Raven T; Ellis L; Gruppuso PA
J Clin Invest; 1992 Jul; 90(1):174-9. PubMed ID: 1321840
[TBL] [Abstract][Full Text] [Related]
17. Impaired insulin action but normal insulin receptor activity in diabetic rat liver: effect of vanadate.
Blondel O; Simon J; Chevalier B; Portha B
Am J Physiol; 1990 Mar; 258(3 Pt 1):E459-67. PubMed ID: 2180315
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of a rat liver protein-tyrosine phosphatase with sequence similarity to src-homology region 2.
Hiraga A; Munakata H; Hata K; Suzuki Y; Tsuiki S
Eur J Biochem; 1992 Oct; 209(1):195-206. PubMed ID: 1382983
[TBL] [Abstract][Full Text] [Related]
19. In vivo modulation of N-myristoyltransferase activity by orthovanadate.
King MJ; Pugazhenthi S; Khandelwal RL; Sharma RK
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):151-5. PubMed ID: 8927031
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cyclic AMP phosphodiesterase activity by particulate protein tyrosine kinase and phosphotyrosine phosphatase activities sensitive to sodium orthovanadate.
Ueki H; Yamasaki Y; Higo K; Motoyashiki T; Kawabata H; Morita T
Biol Pharm Bull; 1995 Feb; 18(2):214-8. PubMed ID: 7742786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
